FBCM
NKGN
Fort Baker Capital Management’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-201,147
| Closed | -$2.08M | – | 98 |
|
|
2023
Q2 | $2.08M | Hold |
201,147
| – | – | 0.28% | 45 |
|
|
2023
Q1 | $2.04M | Hold |
201,147
| – | – | 0.42% | 38 |
|
|
2022
Q4 | $2M | Hold |
201,147
| – | – | 0.61% | 26 |
|
|
2022
Q3 | $1.96M | Sell |
201,147
-100,557
| -33% | -$980K | 0.29% | 34 |
|
|
2022
Q2 | $2.93M | Hold |
301,704
| – | – | 0.46% | 35 |
|
|
2022
Q1 | $2.93M | Buy |
301,704
+276,990
| +1,121% | +$2.69M | 0.45% | 38 |
|
|
2021
Q4 | $240K | Hold |
24,714
| – | – | 0.04% | 69 |
|
|
2021
Q3 | $240K | Buy |
+24,714
| New | +$240K | 0.06% | 78 |
|